Development of a nomogram to predict the risk of hepatocellular carcinoma in patients with hepatitis B-related cirrhosis on antivirals.

Shi, Ke; Li, Ping; Zhang, Qun; Zhang, Yi; Bi, Yufei; Zeng, Xuanwei; Wang, Xianbo

Shi, Ke; Li, Ping; Zhang, Qun; Zhang, Yi; Bi, Yufei; Zeng, Xuanwei; Wang, Xianbo.

Afiliação

Shi K; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Li P; Department of Hepatology, Tianjin Second People's Hospital, Tianjin, China.
Zhang Q; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Zhang Y; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Bi Y; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Zeng X; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
Wang X; Center of Integrative Medicine, Beijing Ditan Hospital, Capital Medical University, Beijing, China.

Front Oncol ; 13: 1128062, 2023.

Article em En | MEDLINE | ID: mdl-36874109

Palavras-chave

cirrhosis; hepatitis B virus; hepatocellular carcinoma; prediction model; risk stratification

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google